General Surgery
Final Professional MBBS — General Surgery. Explanation-first answers that teach the reasoning behind every fact, with classifications, comparison tables, drug doses, clinical pearls and key-point recaps from Bailey & Love and SRB's Manual.
THE CONCEPT
Gallstones (cholelithiasis) form when the normal constituents of bile fall out of balance and precipitate. They are extremely common and most are asymptomatic; the many clinical presentations all depend on where a stone lodges. This single idea — that the disease is defined by the site of obstruction — organises the whole topic, from silent stones to life-threatening cholangitis.
TYPES OF STONES & RISK FACTORS
There are three types: cholesterol stones (from cholesterol supersaturation of bile — the commonest in Western populations), pigment stones (black stones from haemolysis with excess bilirubin, and brown stones from biliary infection/stasis), and mixed stones (commonest overall). The classic risk factors are the 'five Fs' — Female, Forty, Fat, Fertile and Fair — with haemolytic disorders predisposing to pigment stones, and ileal disease (Crohn's) or rapid weight loss also contributing.
PATHOGENESIS
Stone formation needs three elements: supersaturation of bile with cholesterol, nucleation (crystal formation), and gallbladder stasis that allows crystals to aggregate. Understanding this explains why factors that concentrate bile or slow gallbladder emptying promote stones.
THE CLINICAL SPECTRUM
- Asymptomatic — the majority, needing no treatment.
- Biliary colic — a stone transiently obstructs the cystic duct/Hartmann's pouch, causing severe colicky right-upper-quadrant/epigastric pain radiating to the back or right shoulder tip, often after a fatty meal; it is self-limiting and there is no fever or inflammation.
- Acute cholecystitis — persistent cystic-duct obstruction leads to inflammation: constant RUQ pain, fever, a positive Murphy's sign, and leucocytosis.
- Complications — empyema, mucocele, gangrene and perforation; migration into the common bile duct (choledocholithiasis) causing obstructive jaundice, cholangitis or pancreatitis; gallstone ileus; and, in the long term, gallbladder carcinoma.
INVESTIGATION & MANAGEMENT
Ultrasound is the first-line investigation, showing stones, gallbladder wall thickening and any bile-duct dilatation; LFTs and MRCP assess for common-bile-duct stones. Management follows the presentation: asymptomatic stones are left alone; symptomatic stones (biliary colic or cholecystitis) are treated by laparoscopic cholecystectomy; and common-bile-duct stones are removed by ERCP with sphincterotomy.
💡CLINICAL PEARL: The most useful discriminator: biliary colic has no fever and settles, whereas acute cholecystitis has fever, a positive Murphy's sign and inflammatory markers. Ultrasound is the first-line test, and laparoscopic cholecystectomy is the definitive treatment for symptomatic gallstones.COMPLICATIONS IN DETAIL
The complications deserve elaboration because each is a favourite exam topic. A mucocele forms when a stone obstructs the cystic duct and the gallbladder fills with sterile mucus; an empyema is a gallbladder full of pus. Mirizzi syndrome occurs when a stone in Hartmann's pouch compresses the adjacent common hepatic duct, causing obstructive jaundice. Gallstone ileus is small-bowel obstruction from a large stone that has eroded through a cholecysto-duodenal fistula (with air in the biliary tree — pneumobilia — on X-ray). Recognising these explains why symptomatic stones are removed.
CHRONIC CHOLECYSTITIS
Repeated attacks of inflammation produce chronic cholecystitis — a fibrotic, thick-walled, poorly functioning gallbladder — which presents with recurrent biliary pain and fat intolerance. Long-standing inflammation is also the setting for a 'porcelain' (calcified) gallbladder, which carries a raised risk of gallbladder carcinoma. This chronic pathway is part of why elective cholecystectomy is offered for recurrent symptoms rather than waiting for an emergency.
THE COMPLICATIONS OF SURGERY
Laparoscopic cholecystectomy is very safe but the student must know its serious complication — bile duct injury — which can cause bile leak, biliary peritonitis or a stricture, and is minimised by achieving the 'critical view of safety' before dividing structures. Other complications include bleeding, retained CBD stones, and conversion to open surgery. Awareness of these underlies proper consent and the careful identification of anatomy at operation.
BILIARY ANATOMY & CALOT'S TRIANGLE
A working knowledge of biliary anatomy underpins safe surgery. The cystic duct, common hepatic duct and inferior border of the liver bound Calot's triangle, within which the cystic artery runs — the structures the surgeon must positively identify before clipping. Anatomical variations (an aberrant right hepatic artery, a low-inserting cystic duct, or accessory ducts) are common and are the reason the 'critical view of safety' is obtained. This anatomy also explains Mirizzi syndrome, where a stone in the cystic duct/Hartmann's pouch compresses the neighbouring common hepatic duct.
💊KEY POINTS / NUMBERS (viva)- Risk = the five Fs (Female, Forty, Fat, Fertile, Fair); ultrasound is first-line.
- Biliary colic (no fever, self-limiting) vs cholecystitis (fever, Murphy's positive, leucocytosis).
- Symptomatic stones → laparoscopic cholecystectomy; CBD stones → ERCP + sphincterotomy.
🔑KEY POINTS TO REMEMBER- Gallstones = cholesterol, pigment or mixed; risk = five Fs; most are asymptomatic and the presentation depends on where a stone lodges.
- Biliary colic: transient cystic-duct obstruction → colicky RUQ pain to back/shoulder after fatty meals, no fever, self-limiting.
- Acute cholecystitis: persistent obstruction → constant pain, fever, positive Murphy's sign, leucocytosis.
- Complications: empyema/mucocele/gangrene/perforation, CBD stones (jaundice, cholangitis, pancreatitis), gallstone ileus, gallbladder cancer.
- Ultrasound first-line (+ MRCP for CBD stones); laparoscopic cholecystectomy for symptomatic stones; ERCP for CBD stones.
📚SOURCES: Bailey & Love's Short Practice of Surgery; SRB's Manual of Surgery.THE CONCEPT
Obstructive (post-hepatic) jaundice results from a blockage to the flow of bile between the liver and the duodenum. Because conjugated bilirubin cannot reach the gut and refluxes into the blood, it produces a characteristic picture: a raised conjugated bilirubin, dark urine (bilirubin excreted renally), pale 'clay' stools (no bile pigment reaching the gut), and pruritus (from retained bile salts). Recognising this pattern separates surgical (obstructive) jaundice from the medical causes.
CLASSIFYING JAUNDICE
Jaundice is classified by the level of the problem: pre-hepatic (haemolysis — unconjugated bilirubin), hepatic (hepatocellular disease), and post-hepatic/obstructive (conjugated bilirubin — the surgical type discussed here). Distinguishing them clinically and biochemically is the first step.
CAUSES OF OBSTRUCTIVE JAUNDICE
Using the 'lumen / wall / outside the wall' framework:
- In the lumen — common-bile-duct stones (choledocholithiasis), the commonest benign cause.
- In the wall — cholangiocarcinoma, a benign stricture, or a congenital choledochal cyst.
- Outside the wall (compression) — carcinoma of the head of the pancreas and periampullary carcinoma, or nodes at the porta hepatis.
CLINICAL ASSESSMENT & COURVOISIER'S LAW
The history helps identify the cause: painful, fluctuating jaundice with fever suggests stones, whereas painless, progressive jaundice with weight loss suggests malignancy. Courvoisier's law states that in a jaundiced patient, a palpable (non-tender) gallbladder is unlikely to be due to stones — because stones make the gallbladder fibrotic and non-distensible — and therefore points to a malignant obstruction (e.g. carcinoma of the pancreatic head).
INVESTIGATION
LFTs show a cholestatic picture (raised conjugated bilirubin, ALP and GGT). Ultrasound is the first-line image (dilated ducts, level of obstruction); MRCP is the gold-standard non-invasive test to delineate the biliary tree; ERCP is both diagnostic and therapeutic; and CT stages a malignant cause. Crucially, coagulation must be checked, because obstruction impairs absorption of fat-soluble vitamin K.
MANAGEMENT
Management has three strands: relieve the obstruction (ERCP with stone extraction or stenting; surgery for the cause), correct the consequences (vitamin K for coagulopathy, treat pruritus and infection), and treat the underlying cause (stone clearance, or resection such as a Whipple's procedure for a resectable tumour).
💡CLINICAL PEARL: Two facts win marks. The biochemical signature is raised conjugated bilirubin with a high ALP, pale stools and dark urine. And Courvoisier's law — a palpable non-tender gallbladder in a jaundiced patient means the cause is not stones (think malignancy). Always correct clotting with vitamin K before any intervention.CONSEQUENCES OF PROLONGED OBSTRUCTION
Prolonged biliary obstruction has several dangerous consequences beyond the visible jaundice. Failure to absorb fat-soluble vitamins causes vitamin K-dependent coagulopathy (a bleeding risk that must be corrected before any procedure). Stagnant bile predisposes to ascending cholangitis, and severe obstructive jaundice increases the risk of hepatorenal syndrome and acute kidney injury after intervention (so patients are well hydrated peri-operatively). Chronic obstruction ultimately causes secondary biliary cirrhosis.
THE ROLE OF ERCP VS SURGERY
A practical point is choosing the right tool to relieve obstruction. ERCP is ideal for ductal problems — extracting CBD stones after sphincterotomy, or stenting a malignant stricture — and is minimally invasive. Surgery is needed for the underlying cause when it is resectable (e.g. a Whipple's procedure for a periampullary tumour) or for stones not amenable to ERCP. The modern pathway usually combines them: ERCP to decompress and relieve jaundice, then definitive treatment of the cause.
A NOTE ON PAINLESS VS PAINFUL JAUNDICE
The single most useful bedside distinction remains painful versus painless obstructive jaundice. Painful, fluctuating jaundice with fever points to stones and cholangitis, an inflammatory/infective problem. Painless, steadily deepening jaundice with weight loss points to malignancy (pancreatic head/periampullary or cholangiocarcinoma). Reinforced by Courvoisier's law, this distinction shapes the whole investigation pathway from the first consultation.
A STRUCTURED APPROACH TO THE JAUNDICED PATIENT
In practice the jaundiced surgical patient is worked up in a set order: confirm it is conjugated (cholestatic) jaundice on LFTs, then ultrasound to confirm duct dilatation and its level, then MRCP to define the anatomy of the obstruction, proceeding to ERCP when therapy (stone removal or stenting) is needed and to CT when staging a suspected malignancy. Throughout, the clotting is corrected and the patient kept well hydrated. This logical ladder avoids unnecessary invasive tests while reaching a diagnosis and relieving the obstruction efficiently.
💊KEY POINTS / NUMBERS (viva)- Obstructive jaundice = ↑conjugated bilirubin + ↑ALP/GGT + pale stools + dark urine.
- Courvoisier's law: palpable gallbladder in jaundice → not stones (suspect malignancy).
- MRCP is the gold-standard non-invasive test; ERCP is diagnostic + therapeutic; correct coagulopathy with vitamin K.
🔑KEY POINTS TO REMEMBER- Obstructive (post-hepatic) jaundice = blocked bile flow → ↑conjugated bilirubin, dark urine, pale stools, pruritus.
- Causes: CBD stones (commonest benign), cholangiocarcinoma/stricture, carcinoma head of pancreas/periampullary (compression).
- Painful/fluctuating + fever = stones; painless + weight loss = malignancy; Courvoisier's law (palpable gallbladder → not stones).
- LFTs (cholestatic), ultrasound, MRCP (gold-standard non-invasive), ERCP (diagnostic + therapeutic), CT for malignancy; check clotting.
- Relieve obstruction (ERCP/stent/surgery), correct coagulopathy (vitamin K), treat the cause (stones or resection e.g. Whipple's).
📚SOURCES: Bailey & Love's Short Practice of Surgery; SRB's Manual of Surgery.THE CONCEPT — AUTODIGESTION
Acute pancreatitis is acute inflammation of the pancreas caused by the premature activation of its own digestive enzymes within the gland, so that the pancreas begins to digest itself. This 'autodigestion' triggers inflammation, oedema and, in severe cases, necrosis, and can spill over into a systemic inflammatory response affecting the whole body. Understanding it as an enzyme-activation problem explains both the local and systemic effects.
CAUSES
The two dominant causes are gallstones and alcohol, which together account for most cases. The fuller list is remembered by 'GET SMASHED': Gallstones, Ethanol, Trauma, Steroids, Mumps (and other infections), Autoimmune, Scorpion sting, Hyperlipidaemia/Hypercalcaemia, ERCP, and Drugs.
PATHOPHYSIOLOGY
Whatever the trigger, there is premature intra-acinar activation of trypsinogen to trypsin, which then activates the other pancreatic enzymes. These digest the gland and surrounding tissue, causing inflammation, interstitial oedema, fat necrosis and, in severe disease, haemorrhagic necrosis. Released enzymes and inflammatory mediators drive a systemic inflammatory response (SIRS) and massive third-space fluid loss.
CLINICAL FEATURES
The classic presentation is severe, constant epigastric pain radiating through to the back, relieved by sitting forward, with nausea and vomiting. Examination shows epigastric tenderness. In severe disease, tracking of haemorrhagic fluid produces the eponymous bruising signs: Cullen's sign (periumbilical) and Grey Turner's sign (flanks).
INVESTIGATION & SEVERITY
Diagnosis rests on a serum amylase or lipase raised more than three times the upper limit of normal (lipase is more specific and stays elevated longer). Ultrasound looks for gallstones as the cause, and contrast CT (after 48–72 hours) assesses necrosis and complications. Severity scores — Glasgow, Ranson, APACHE II, with CRP — identify severe attacks needing intensive care.
COMPLICATIONS & MANAGEMENT
Local complications include necrosis, pseudocyst, abscess and haemorrhage; systemic complications include shock, ARDS, acute kidney injury, hypocalcaemia, DIC and multi-organ failure. Management is largely supportive: aggressive intravenous fluid resuscitation, analgesia, oxygen, careful monitoring (often in HDU/ICU for severe cases) and nutritional support. The cause is then treated — cholecystectomy for gallstone pancreatitis (or urgent ERCP if there is co-existing cholangitis) — and complications such as infected necrosis may need necrosectomy.
💡CLINICAL PEARL: Anchor it on: gallstones and alcohol as the two big causes; amylase/lipase >3× normal for diagnosis; Cullen's and Grey Turner's signs in severe disease; and the principle that treatment is largely supportive (fluids, analgesia, organ support) — there is no specific 'cure', so early aggressive fluid resuscitation and severity scoring drive outcomes.THE PROGNOSTIC SCORING SYSTEMS
Because a minority of attacks are severe and life-threatening, early severity stratification is central to management. The Glasgow (Imrie) and Ranson criteria use parameters such as age, white cell count, glucose, urea, calcium, albumin, LDH and PaO2 measured over the first 48 hours, and APACHE II and serial CRP add to this. Identifying a predicted-severe attack triggers early transfer to a high-dependency or intensive-care setting, where aggressive support improves survival.
LOCAL COMPLICATIONS & THEIR TIMING
The local complications evolve over time, which guides when to image and intervene. Early there is peripancreatic fluid and necrosis; if necrosis becomes infected (usually after the first week) it is life-threatening and needs intervention (increasingly a 'step-up' approach of drainage then minimally invasive necrosectomy rather than early open surgery). Later, a pseudocyst may mature, and erosion into a vessel can cause haemorrhage or a pseudoaneurysm. Contrast CT after 48–72 hours is timed to detect necrosis reliably.
THE PRINCIPLE OF SUPPORTIVE CARE
It is worth stressing that there is no drug that cures acute pancreatitis — outcome depends on excellent supportive care: aggressive early fluid resuscitation to counter the massive third-space loss, analgesia, oxygen, correction of electrolytes (including calcium), and early enteral nutrition where possible (which protects the gut barrier). Antibiotics are reserved for proven infection. Definitive treatment of the cause (cholecystectomy for gallstones, ideally on the same admission for mild disease) prevents recurrence.
GALLSTONE PANCREATITIS — A SPECIAL CASE
Gallstone pancreatitis deserves specific mention because it has a defined pathway. A stone passing through or impacted at the ampulla of Vater obstructs the pancreatic duct and triggers the attack. If it is accompanied by cholangitis or persistent obstruction, urgent ERCP with sphincterotomy relieves it; and once a mild attack settles, a cholecystectomy is performed on the same admission to prevent a further, possibly fatal, attack. This makes identifying gallstones as the cause (on ultrasound and LFTs) an early priority in every case of pancreatitis.
💊KEY POINTS / NUMBERS (viva)- Two main causes: gallstones and alcohol (full list = 'GET SMASHED').
- Diagnosis: amylase or lipase >3× upper limit of normal (lipase more specific).
- Management is supportive (aggressive IV fluids, analgesia, organ support); score severity (Glasgow/Ranson/APACHE).
🔑KEY POINTS TO REMEMBER- Acute pancreatitis = autodigestion from premature intra-acinar enzyme (trypsin) activation.
- Two main causes: gallstones and alcohol ('GET SMASHED' for the rest).
- Severe constant epigastric pain radiating to back, relieved leaning forward, with vomiting; Cullen's/Grey Turner's signs if severe.
- Diagnose with amylase/lipase >3× normal; ultrasound for gallstones; CT (48–72 h) for necrosis; score severity (Glasgow/Ranson/APACHE, CRP).
- Treatment is supportive (aggressive fluids, analgesia, organ support); treat cause (cholecystectomy/ERCP); necrosectomy for infected necrosis.
📚SOURCES: Bailey & Love's Short Practice of Surgery; SRB's Manual of Surgery.THE CONCEPT
Carcinoma of the pancreas is usually a ductal adenocarcinoma, and it is one of the most lethal of cancers because it presents late and behaves aggressively. About two-thirds arise in the head of the gland, where they tend to cause obstructive jaundice relatively early; tumours of the body and tail present later (with pain) and carry an even worse prognosis. Its location relative to the bile duct largely determines how it presents.
RISK FACTORS
The main risk factors are smoking (the strongest modifiable factor), chronic pancreatitis, diabetes mellitus, increasing age, obesity, and a family history.
CLINICAL FEATURES
- Head of pancreas — painless, progressive obstructive jaundice (with pale stools, dark urine, pruritus), classically with a palpable gallbladder (Courvoisier's law), and weight loss.
- Body/tail — epigastric pain radiating to the back and weight loss, presenting late.
- General — anorexia and marked weight loss, new-onset diabetes, and migratory thrombophlebitis (Trousseau's sign).
INVESTIGATION & STAGING
A pancreatic-protocol CT is central — it demonstrates the tumour and, critically, assesses resectability (involvement of the major vessels). CA 19-9 is a useful tumour marker for support and follow-up (not screening). MRCP/ERCP assesses the biliary obstruction (and allows stenting), endoscopic ultrasound with biopsy gives tissue, and staging laparoscopy detects peritoneal spread.
MANAGEMENT
Sadly, only a minority are resectable at diagnosis:
- Resectable disease (mostly head tumours) — a Whipple's procedure (pancreaticoduodenectomy), removing the head of pancreas, duodenum, distal bile duct and part of the stomach, followed by adjuvant chemotherapy.
- Unresectable or metastatic disease (the majority) — palliation: relieving jaundice with a biliary stent, controlling pain (including a coeliac plexus block), relieving duodenal obstruction (stent/bypass), and palliative chemotherapy.
💡CLINICAL PEARL: The classic exam picture: painless obstructive jaundice + a palpable gallbladder (Courvoisier) + weight loss = carcinoma of the head of the pancreas. Remember CA 19-9 as the marker, the Whipple's procedure for the few resectable tumours, and Trousseau's sign of migratory thrombophlebitis as a paraneoplastic clue.WHY THE PROGNOSIS IS SO POOR
The dismal outlook has clear reasons worth articulating. The pancreas has no capsule and a rich lymphatic and neural network, so tumours spread early — to lymph nodes, along nerves (causing the boring back pain), into the portal/mesenteric vessels, and to the liver and peritoneum. Symptoms are vague until the tumour obstructs the bile duct or invades locally, so most present with unresectable or metastatic disease. This biology, not a lack of treatment, is why five-year survival remains very low.
ASSESSING RESECTABILITY
The pivotal decision is whether the tumour is resectable, which turns on its relationship to the major vessels (the superior mesenteric artery and vein, portal vein and coeliac axis) on a dedicated pancreatic-protocol CT. Tumours are classified as resectable, 'borderline resectable', or locally advanced/metastatic. This assessment — together with staging laparoscopy to exclude peritoneal disease — determines whether a patient is offered a major curative operation or directed to palliation, sparing unfit or incurable patients futile surgery.
PALLIATION IN DETAIL
Since most patients are palliative, relieving symptoms well is central. The three cardinal palliative problems are jaundice, duodenal obstruction and pain: jaundice is relieved by an endoscopic biliary stent (or a surgical bypass), gastric outlet/duodenal obstruction by a duodenal stent or gastrojejunostomy, and the characteristic back pain by strong analgesia and a coeliac plexus block/neurolysis. Palliative chemotherapy may prolong life, and early palliative-care involvement improves quality of life.
A NOTE ON PERIAMPULLARY TUMOURS
It is worth distinguishing pancreatic head cancer from the other 'periampullary' tumours — cancers of the ampulla of Vater, the distal bile duct, and the duodenum — which cluster around the same region and also present with obstructive jaundice. They are grouped because they are treated by the same operation (a Whipple's procedure), but ampullary and duodenal tumours generally have a better prognosis than pancreatic ductal adenocarcinoma, and may present earlier (with jaundice or bleeding). Recognising this group refines both the assessment and the prognostic discussion.
💊KEY POINTS / NUMBERS (viva)- Painless obstructive jaundice + palpable gallbladder (Courvoisier) + weight loss = carcinoma head of pancreas.
- CA 19-9 is the tumour marker (support/follow-up, not screening); pancreatic-protocol CT assesses resectability.
- Resectable head tumour → Whipple's (pancreaticoduodenectomy) + adjuvant chemo; most get palliation (biliary stent, chemo).
🔑KEY POINTS TO REMEMBER- Usually ductal adenocarcinoma, most in the head; late, aggressive presentation and poor prognosis.
- Risk: smoking (strongest), chronic pancreatitis, diabetes, age, obesity, family history.
- Head → painless obstructive jaundice + palpable gallbladder (Courvoisier) + weight loss; body/tail → back pain, late; also new diabetes, Trousseau's sign.
- Pancreatic-protocol CT (diagnosis + resectability); CA 19-9 marker; MRCP/ERCP, EUS-biopsy, staging laparoscopy.
- Whipple's procedure for the few resectable tumours (+ adjuvant chemo); palliation (biliary stent, pain control, chemo) for the majority.
📚SOURCES: Bailey & Love's Short Practice of Surgery; SRB's Manual of Surgery.THE CONCEPT
Portal hypertension is a sustained rise in the pressure within the portal venous system (normally only ~5–8 mmHg), becoming clinically important above ~10–12 mmHg. It arises from obstruction to portal blood flow, and its dangerous consequences all follow from the body's response to that obstruction: blood is forced through porto-systemic collateral channels, the spleen enlarges, and fluid accumulates as ascites. Grasping this 'back-pressure with collaterals' concept explains every complication.
CAUSES — BY SITE OF OBSTRUCTION
Level Causes Pre-hepatic Portal or splenic vein thrombosis Hepatic Cirrhosis (commonest overall); schistosomiasis (common worldwide) Post-hepatic Budd-Chiari syndrome (hepatic vein thrombosis), constrictive pericarditis, right heart failure CONSEQUENCES
- Porto-systemic collaterals — oesophageal and gastric varices (which can bleed catastrophically), caput medusae (peri-umbilical veins) and rectal varices.
- Splenomegaly → hypersplenism (pancytopenia).
- Ascites.
- Hepatic encephalopathy (toxins bypassing the liver).
CLINICAL FEATURES & INVESTIGATION
Patients show features of chronic liver disease plus the effects of portal hypertension — splenomegaly, ascites, and above all variceal bleeding (haematemesis and melaena). Investigation includes upper GI endoscopy (to identify and treat varices), ultrasound with Doppler (portal flow, spleen size), LFTs and clotting, and assessment of liver reserve with the Child-Pugh score.
MANAGEMENT OF VARICES
- Acute variceal bleed — resuscitate, give a vasoactive drug (terlipressin or octreotide) and prophylactic antibiotics, and perform endoscopic band ligation (or sclerotherapy); balloon tamponade (Sengstaken-Blakemore tube) is a temporising rescue, and TIPS (transjugular intrahepatic porto-systemic shunt) is used for uncontrolled bleeding.
- Prevention — non-selective beta-blockers (propranolol) and repeated band ligation reduce the risk of (re)bleeding.
- Definitive — treat the underlying liver disease; TIPS or shunt surgery; and, ultimately, liver transplantation.
💡CLINICAL PEARL: The essentials: cirrhosis is the commonest cause; oesophageal varices are the lethal consequence; an acute variceal bleed is managed with resuscitation + terlipressin + prophylactic antibiotics + endoscopic band ligation; propranolol prevents rebleeding; and the Child-Pugh score grades liver function and prognosis.PATHOPHYSIOLOGY OF THE COMPLICATIONS
The complications become logical once the haemodynamics are understood. Obstruction raises portal pressure, forcing blood through porto-systemic anastomoses (lower oesophagus, umbilicus, rectum) which dilate into varices; the same back-pressure and splanchnic vasodilatation, combined with low albumin and sodium retention, drive ascites; congestion enlarges the spleen, causing hypersplenism; and blood bypassing the liver allows gut-derived toxins (ammonia) to reach the brain, causing encephalopathy. Every clinical feature traces back to raised portal pressure.
VARICEAL BLEEDING — A CLOSER LOOK
Variceal haemorrhage is the feared, often fatal, event. Management is a well-drilled sequence: resuscitate (protect the airway, transfuse judiciously), start a vasoactive drug (terlipressin/octreotide) to lower portal pressure and prophylactic antibiotics (which independently improve survival by preventing infection), then endoscopic band ligation to control the bleeding point. Uncontrolled bleeding is temporised with balloon tamponade and definitively treated with TIPS. After recovery, secondary prevention with beta-blockers and repeated banding is essential.
ASSESSING LIVER RESERVE
Because most portal hypertension is due to cirrhosis, assessing liver functional reserve is crucial for prognosis and treatment choices. The Child-Pugh score (bilirubin, albumin, INR, ascites, encephalopathy) and the MELD score grade severity and predict mortality, and they influence decisions such as suitability for TIPS or transplantation. This is why liver function, not just the varices, is central to managing the portal-hypertensive patient.
MANAGEMENT OF ASCITES & ENCEPHALOPATHY
Beyond varices, the other consequences of portal hypertension need management. Ascites is treated with salt restriction and diuretics (spironolactone ± furosemide), with therapeutic paracentesis for tense ascites and vigilance for spontaneous bacterial peritonitis (a life-threatening infection of ascitic fluid requiring antibiotics). Hepatic encephalopathy is managed by treating precipitants (infection, bleeding, constipation) and giving lactulose and rifaximin to reduce ammonia. Managing the cirrhotic patient therefore extends well beyond the varices to the whole syndrome of decompensated liver disease.
💊KEY POINTS / NUMBERS (viva)- Cirrhosis is the commonest cause; oesophageal varices are the key danger.
- Acute variceal bleed: resuscitate + terlipressin/octreotide + antibiotics + endoscopic band ligation (± Sengstaken tube, TIPS).
- Prevention: non-selective beta-blocker (propranolol) + band ligation; grade with Child-Pugh.
🔑KEY POINTS TO REMEMBER- Portal hypertension = sustained rise in portal pressure from obstruction to flow → collaterals, splenomegaly, ascites.
- Causes: pre-hepatic (portal vein thrombosis), hepatic (cirrhosis commonest; schistosomiasis), post-hepatic (Budd-Chiari).
- Consequences: oesophageal/gastric varices (bleeding), caput medusae, hypersplenism, ascites, encephalopathy.
- Endoscopy (varices), Doppler ultrasound, Child-Pugh score for liver function.
- Acute bleed: resuscitate + terlipressin + antibiotics + band ligation (± tamponade/TIPS); prevent with propranolol + banding; transplant is definitive.
📚SOURCES: Bailey & Love's Short Practice of Surgery; Davidson's Principles and Practice of Medicine.THE CONCEPT
Acute cholecystitis is acute inflammation of the gallbladder, and in over 90% of cases it is calculous — caused by a stone impacting in the cystic duct or Hartmann's pouch. The persistent obstruction causes the gallbladder to distend, its wall to become inflamed and oedematous, and secondary bacterial infection to supervene. This is the key difference from biliary colic, where the obstruction is only transient and there is no inflammation.
CLINICAL FEATURES
There is constant right-upper-quadrant or epigastric pain (unlike the colicky, self-limiting pain of biliary colic), often radiating to the right shoulder, with fever, nausea and vomiting. The classic sign is Murphy's sign — the patient catches their breath (arrest of inspiration) as the examiner's hand presses the inflamed gallbladder against it during deep inspiration in the RUQ. Blood tests show a neutrophil leucocytosis and raised CRP.
INVESTIGATION & MANAGEMENT
Ultrasound confirms the diagnosis, showing gallstones, a thick-walled gallbladder and pericholecystic fluid, often with a sonographic Murphy's sign. Management is analgesia, intravenous fluids and antibiotics, followed by laparoscopic cholecystectomy — ideally early ('hot' gallbladder, within about 72 hours), or as an interval procedure. Complications of untreated disease include empyema, gangrene and perforation of the gallbladder.
ACALCULOUS CHOLECYSTITIS
A minority (~5–10%) have acalculous cholecystitis — inflammation without stones — occurring typically in critically ill, fasting or post-operative patients from gallbladder stasis and ischaemia. It is easily missed and carries a higher risk of gangrene, so a high index of suspicion is needed in the sick patient.
EARLY VS DELAYED SURGERY
There is a clear rationale for early ('hot') laparoscopic cholecystectomy within about 72 hours of onset: operating during the acute window (before dense adhesions form) is safe and avoids the risk of recurrent attacks while waiting. Beyond that window, if presentation is late, some surgeons prefer to cool the inflammation and perform an interval cholecystectomy some weeks later. Either way, definitive removal of the gallbladder is the goal, since attacks recur.
THE BOTTOM LINE
Acute cholecystitis is thus a stone-obstructed, inflamed (± infected) gallbladder — constant pain, fever, positive Murphy's sign — confirmed on ultrasound and treated with antibiotics and laparoscopic cholecystectomy, with acalculous disease a trap in the critically ill.
COMPLICATIONS TO ANTICIPATE
The complications of untreated acute cholecystitis form a progression the clinician must anticipate: a mucocele or empyema (a pus-filled gallbladder), then gangrene from pressure necrosis, and finally perforation — either localised (a pericholecystic abscess) or free (biliary peritonitis). Elderly and diabetic patients are especially prone to gangrene. Recognising a patient who is failing to settle, becoming more toxic, or developing a spreading peritonitis mandates urgent intervention rather than continued conservative treatment.
🔑KEY POINTS TO REMEMBER- Acute cholecystitis = gallbladder inflammation, usually from a stone impacted in the cystic duct (calculous).
- Constant RUQ pain (not colicky), fever, vomiting, positive Murphy's sign, leucocytosis.
- Ultrasound: stones, thick wall, pericholecystic fluid.
- Treat with analgesia, IV fluids, antibiotics + laparoscopic cholecystectomy (early, ~within 72 h); complications: empyema, gangrene, perforation.
- Acalculous cholecystitis occurs in the critically ill/post-operative patient (stasis/ischaemia).
📚SOURCES: Bailey & Love's Short Practice of Surgery.THE CONCEPT
Ascending cholangitis is a bacterial infection of the biliary tree, and it requires two ingredients: biliary obstruction and stasis (most often from a common-bile-duct stone, also strictures or tumours) plus bacterial contamination of the static bile. The infected bile under pressure can rapidly spill bacteria into the bloodstream, so cholangitis is a potentially life-threatening emergency, not merely a local infection.
CLINICAL FEATURES — CHARCOT & REYNOLDS
The classic presentation is Charcot's triad: fever with rigors, right-upper-quadrant pain, and jaundice. When infection becomes severe and suppurative, two further features are added to make Reynolds' pentad: hypotension (septic shock) and confusion (altered mental state) — indicating a critically ill patient needing urgent decompression.
INVESTIGATION & MANAGEMENT
Investigations show obstructive LFTs, raised inflammatory markers and positive blood cultures; ultrasound/MRCP confirm biliary obstruction and its cause. Management has three components: resuscitation (fluids, correct coagulopathy), intravenous broad-spectrum antibiotics, and — the definitive step — urgent biliary drainage, usually by ERCP with sphincterotomy and stone extraction or stenting. Prompt decompression is what saves life in severe cholangitis.
WHY URGENT DECOMPRESSION SAVES LIFE
The defining principle of cholangitis is that antibiotics alone are not enough — the infected bile is under pressure behind an obstruction, so unless the biliary tree is decompressed, sepsis progresses. This is why urgent biliary drainage (usually ERCP) is the definitive treatment, and why a patient with Reynolds' pentad who is deteriorating needs emergency decompression rather than continued medical therapy.
THE BOTTOM LINE
Ascending cholangitis is a biliary emergency: Charcot's triad (± Reynolds' pentad) from an obstructed, infected biliary tree, treated by resuscitation, antibiotics and, definitively, urgent biliary drainage.
A NOTE ON ORGANISMS & SEVERITY
The organisms in cholangitis are typically gut-derived Gram-negatives (E. coli, Klebsiella) and anaerobes, which is why empirical antibiotics cover these, and why blood cultures are taken. Severity is graded (mild, moderate, severe) using the degree of organ dysfunction, and severe (suppurative) cholangitis with Reynolds' pentad is a life-threatening emergency demanding admission to high-dependency care and the most urgent possible biliary decompression. This grading determines the speed of intervention.
🔑KEY POINTS TO REMEMBER- Ascending cholangitis = biliary infection from obstruction/stasis (usually a CBD stone) + bacterial contamination — an emergency.
- Charcot's triad: fever/rigors + RUQ pain + jaundice.
- Reynolds' pentad adds hypotension + confusion (severe/suppurative).
- Obstructive LFTs, raised inflammatory markers, blood cultures; ultrasound/MRCP for the cause.
- Treat: resuscitate + IV antibiotics + urgent biliary drainage (ERCP + sphincterotomy/stone removal/stent).
📚SOURCES: Bailey & Love's Short Practice of Surgery.THE CONCEPT
Chronic pancreatitis is a continuing inflammatory process that causes irreversible fibrosis and destruction of the pancreatic parenchyma, progressively wrecking both its exocrine (digestive-enzyme) and endocrine (insulin) functions. Unlike the acute disease, the damage is permanent and cumulative. The commonest cause by far is chronic alcohol excess; other causes include gallstones, hereditary and autoimmune pancreatitis, and hypercalcaemia.
CLINICAL FEATURES
The dominant symptom is chronic, severe epigastric pain radiating to the back (often relieved by leaning forward), frequently with weight loss. As the gland is destroyed, two functional failures appear: exocrine insufficiency → steatorrhoea and malabsorption (pale, fatty, offensive stools), and endocrine insufficiency → diabetes mellitus.
INVESTIGATION & MANAGEMENT
Imaging is key: CT or plain X-ray may show pancreatic calcification (characteristic), and MRCP shows ductal changes; faecal elastase is low, confirming exocrine insufficiency. Management is largely medical and supportive: pain control, pancreatic enzyme replacement (for steatorrhoea), insulin (for diabetes), and abstinence from alcohol. Endoscopic or surgical intervention is reserved for complications (an obstructed duct, a pseudocyst, or intractable pain). Chronic pancreatitis carries an increased risk of pancreatic carcinoma.
CONTRAST WITH ACUTE PANCREATITIS
It helps to contrast chronic with acute pancreatitis: the acute form is a reversible episode of autodigestion with markedly raised amylase, whereas the chronic form is progressive, irreversible fibrosis in which amylase may be normal (the gland is 'burnt out'). This is why diagnosis of chronic disease relies on imaging (calcification, ductal change) and functional tests (low faecal elastase) rather than enzyme levels.
THE BOTTOM LINE
Chronic pancreatitis is irreversible pancreatic fibrosis (usually alcoholic) causing pain, steatorrhoea and diabetes, managed by pain control, enzyme replacement, insulin and abstinence, with surgery for complications.
COMPLICATIONS & THEIR MANAGEMENT
Chronic pancreatitis causes several complications the surgeon treats: a pseudocyst, biliary or duodenal obstruction from the fibrosed head, pancreatic ascites or a fistula, splenic vein thrombosis (causing left-sided portal hypertension and gastric varices), and intractable pain. Persistent, disabling pain or an obstructed, dilated duct may be treated by endoscopic drainage or by surgery (a drainage or resection procedure). Lifelong management of exocrine and endocrine failure runs alongside treating these complications.
🔑KEY POINTS TO REMEMBER- Chronic pancreatitis = irreversible fibrosis/destruction of the pancreas; commonest cause is alcohol.
- Chronic epigastric pain radiating to back + weight loss; exocrine failure → steatorrhoea; endocrine failure → diabetes.
- CT shows pancreatic calcification; MRCP shows ductal change; faecal elastase low.
- Treat with pain control, pancreatic enzyme replacement, insulin, alcohol abstinence; endoscopy/surgery for complications.
- Increased risk of pancreatic carcinoma.
📚SOURCES: Bailey & Love's Short Practice of Surgery.THE CONCEPT
Carcinoma of the gallbladder is an uncommon but aggressive adenocarcinoma strongly associated with gallstones and the chronic inflammation they cause. The great majority of patients have gallstones, and a 'porcelain' (calcified) gallbladder — the end-stage of chronic inflammation — carries a particularly high risk. It is commonest in elderly women, mirroring the epidemiology of gallstones.
CLINICAL FEATURES
Its danger lies in a late, non-specific presentation that mimics benign gallstone disease — right-upper-quadrant pain, a palpable mass, weight loss, and obstructive jaundice (when it invades the bile duct or porta hepatis). By the time these appear the disease is often advanced. Not uncommonly it is discovered incidentally in a gallbladder removed for presumed benign stone disease.
INVESTIGATION, MANAGEMENT & PROGNOSIS
Diagnosis and staging use ultrasound and CT/MRI. Treatment depends on stage: an early cancer (or one found incidentally after cholecystectomy) may be curable by radical cholecystectomy with resection of the adjacent liver bed and regional lymph nodes, but most present late and receive palliative care (biliary stenting, chemotherapy). The overall prognosis is poor because of late presentation and early spread to the liver and nodes.
THE INCIDENTAL CANCER
An important practical scenario is the gallbladder carcinoma found incidentally by the pathologist after a routine cholecystectomy for gallstones. Management then depends on the depth of invasion: a very early (mucosal) cancer may be cured by the cholecystectomy alone, whereas deeper invasion mandates a second, radical operation (liver bed resection and lymphadenectomy). This is why every removed gallbladder is examined histologically.
THE BOTTOM LINE
Gallbladder carcinoma is a gallstone-associated, late-presenting adenocarcinoma with a poor prognosis, curable only when early or incidental, and otherwise palliated.
THE ROLE OF EARLY DETECTION
Because gallbladder carcinoma is curable only when caught early, features that should raise suspicion in a patient with gallstones are worth knowing: a focal thickening or mass in the gallbladder wall, a polyp larger than 1 cm, a 'porcelain' gallbladder, and new persistent symptoms in an older patient. These findings prompt cross-sectional imaging and consideration of cholecystectomy, offering the only realistic chance of detecting the disease at a curable stage.
🔑KEY POINTS TO REMEMBER- Gallbladder carcinoma = aggressive adenocarcinoma associated with gallstones/chronic inflammation and 'porcelain' gallbladder; elderly women.
- Late, non-specific presentation mimicking benign disease: RUQ pain, mass, weight loss, obstructive jaundice; often found incidentally at cholecystectomy.
- Ultrasound + CT/MRI for diagnosis/staging.
- Early → radical cholecystectomy + liver bed + node resection; most present late → palliation.
- Poor prognosis (late presentation, early liver/nodal spread).
📚SOURCES: Bailey & Love's Short Practice of Surgery.THE CONCEPT — TWO MAIN TYPES
A liver abscess is a localised collection of pus within the liver, and the two important types have quite different origins. A pyogenic (bacterial) abscess arises when bacteria reach the liver — most often via the biliary tree (ascending cholangitis) or the portal vein (e.g. from appendicitis or diverticulitis) — and is frequently polymicrobial (E. coli and others). An amoebic abscess is caused by Entamoeba histolytica, spreading from a colonic infection via the portal vein, and characteristically affects young men and the right lobe, containing sterile 'anchovy sauce' pus.
CLINICAL FEATURES
Both present with swinging fever, right-upper-quadrant pain and a tender, enlarged liver, with malaise and weight loss. A history of dysentery or travel to an endemic area suggests an amoebic cause, while a biliary or abdominal source suggests a pyogenic one.
DIAGNOSIS & MANAGEMENT
Ultrasound or CT localises the abscess; amoebic serology supports that diagnosis; blood cultures and aspiration guide antibiotics in pyogenic cases. Treatment differs by type: a pyogenic abscess needs broad-spectrum antibiotics plus drainage (usually percutaneous) and treatment of the source; an amoebic abscess responds well to metronidazole (followed by a luminal agent to clear intestinal carriage), with aspiration reserved for large abscesses, a left-lobe abscess threatening rupture, or failure to respond.
DISTINGUISHING THE TWO TYPES
Distinguishing amoebic from pyogenic abscess matters because treatment differs. Features favouring amoebic are a young man, a single right-lobe abscess, a history of dysentery or travel to an endemic area, and positive serology; features favouring pyogenic are an older patient, an obvious biliary or abdominal source, multiple abscesses, and positive blood cultures. The amoebic abscess usually responds to metronidazole alone, whereas the pyogenic abscess needs drainage plus antibiotics.
THE BOTTOM LINE
A liver abscess is pyogenic (biliary/portal, drained + antibiotics) or amoebic (Entamoeba, right lobe, 'anchovy sauce' pus, metronidazole), distinguished by clinical context and serology.
COMPLICATIONS & DRAINAGE
Both types of liver abscess can cause dangerous complications — rupture (into the pleura, peritoneum or pericardium), secondary infection of an amoebic abscess, and ongoing sepsis. This is why large abscesses, those failing to respond to drug therapy, and left-lobe amoebic abscesses (which may rupture into the pericardium) are drained percutaneously under imaging. Alongside drainage, the underlying source — a biliary obstruction or an intra-abdominal focus for pyogenic abscess, or intestinal amoebiasis for the amoebic type — must be identified and treated.
🔑KEY POINTS TO REMEMBER- Liver abscess: pyogenic (bacterial, via biliary tree or portal vein, often polymicrobial/E. coli) vs amoebic (Entamoeba histolytica, portal spread from colon, right lobe, 'anchovy sauce' pus, young men).
- Swinging fever, RUQ pain, tender hepatomegaly, weight loss.
- Ultrasound/CT localises; amoebic serology; blood cultures/aspiration for pyogenic.
- Pyogenic → antibiotics + drainage + treat source; amoebic → metronidazole (+ luminal agent), aspirate if large/left-lobe/no response.
📚SOURCES: Bailey & Love's Short Practice of Surgery.THE CONCEPT
A pancreatic pseudocyst is a collection of pancreatic fluid (rich in amylase) walled off by a wall of granulation and fibrous tissue. It is called a 'pseudo'cyst because it lacks a true epithelial lining — the wall is inflammatory tissue, not epithelium. It typically develops as a complication of acute or chronic pancreatitis (or pancreatic trauma), usually appearing about four or more weeks after the acute episode, the time needed for the wall to mature.
CLINICAL FEATURES
A pseudocyst may be asymptomatic or present with persistent epigastric pain, a palpable epigastric mass, early satiety or nausea (from pressure on the stomach), and a persistently raised serum amylase. It should be suspected when a patient recovering from pancreatitis fails to settle or develops a mass.
INVESTIGATION, COMPLICATIONS & MANAGEMENT
CT or ultrasound confirms and characterises the collection. Many small, asymptomatic pseudocysts resolve spontaneously and can be observed. Drainage is indicated for those that are large, persistent, symptomatic or complicated — the preferred route is often endoscopic (cystogastrostomy), with surgical drainage as an alternative. Complications that force intervention include infection (an abscess), haemorrhage (erosion into a vessel), rupture, and obstruction of adjacent structures.
DISTINGUISHING FROM OTHER CYSTS
A pseudocyst must be distinguished from a true cystic neoplasm of the pancreas (such as a mucinous cystic neoplasm), which has malignant potential and is managed quite differently. The clinical context (a preceding attack of pancreatitis), the fluid characteristics (high amylase) and imaging features help make this distinction — an important step, because draining a cystic tumour as if it were a pseudocyst would be a serious error.
THE BOTTOM LINE
A pancreatic pseudocyst is a walled-off, epithelium-free collection of amylase-rich fluid after pancreatitis; small ones resolve, while large, symptomatic or complicated ones are drained (usually endoscopically).
COMPLICATIONS & TIMING OF DRAINAGE
The timing of intervention matters: a pseudocyst wall needs about 4–6 weeks to mature before it can safely hold sutures or an endoscopic stent, so drainage of a stable cyst is generally deferred until then. Complications that force earlier action include infection (turning it into an abscess), haemorrhage from erosion into a splenic or gastroduodenal vessel (which may need angiographic embolisation), rupture, and gastric outlet or biliary obstruction from the enlarging cyst.
🔑KEY POINTS TO REMEMBER- Pancreatic pseudocyst = walled-off collection of pancreatic (amylase-rich) fluid with a fibrous/granulation wall (no epithelial lining), after pancreatitis/trauma, usually >4 weeks later.
- Epigastric pain, palpable mass, early satiety/nausea, persistently raised amylase.
- CT/ultrasound confirms; many small ones resolve spontaneously.
- Drain (endoscopic cystogastrostomy or surgical) if large, persistent, symptomatic or complicated (infection, haemorrhage, rupture, obstruction).
📚SOURCES: Bailey & Love's Short Practice of Surgery.THE CONCEPT — A PARASITIC CYST
A hydatid cyst is a parasitic cyst caused by the larval stage of the dog tapeworm Echinococcus granulosus. Humans are an accidental intermediate host, becoming infected by ingesting the eggs (from contact with dogs or contaminated food); the usual definitive host is the dog and the natural intermediate host the sheep. The larvae travel via the portal vein, so the liver (especially the right lobe) is the commonest site. The cyst grows slowly over years and has a characteristic structure of an outer host-derived layer, a middle laminated membrane, and an inner germinal layer that buds 'daughter cysts'.
CLINICAL FEATURES & COMPLICATIONS
Small cysts are often asymptomatic, discovered incidentally. Larger cysts cause a right-upper-quadrant mass, dull pain or hepatomegaly. The important complications are rupture (releasing highly antigenic fluid that can cause anaphylaxis and disseminate daughter cysts), secondary bacterial infection, and rupture into the biliary tree causing obstruction or cholangitis.
DIAGNOSIS & MANAGEMENT
Ultrasound and CT are diagnostic, showing a cyst with internal daughter cysts and a detached membrane ('water-lily sign'); serology (ELISA) supports the diagnosis (the older Casoni skin test is now obsolete). Treatment combines anti-helminthic drugs (albendazole) with definitive removal — either the minimally invasive PAIR technique (Puncture, Aspiration, Injection of a scolicidal agent, and Re-aspiration) or surgery (pericystectomy/cystectomy). The cardinal rule is to avoid spillage of cyst contents — which risks anaphylaxis and dissemination — by injecting a scolicidal agent (e.g. hypertonic saline) and protecting the field.
💡CLINICAL PEARL: The rule that must be stated: never allow spillage of hydatid cyst fluid — it can cause fatal anaphylaxis and seed new cysts throughout the abdomen. The field is protected and a scolicidal agent instilled before the cyst is opened, and albendazole is given around the procedure.PREVENTION & PUBLIC HEALTH
Because hydatid disease is transmitted through the dog-sheep cycle, prevention is a public-health matter: avoiding the feeding of infected offal to dogs, deworming dogs, safe disposal of infected carcasses, and good personal hygiene (hand-washing after animal contact). In endemic regions this cycle is common, which is why hydatid disease must be considered in any slow-growing liver cyst in a patient from such an area.
THE BOTTOM LINE
A hydatid cyst is a slow-growing parasitic liver cyst from Echinococcus, diagnosed on imaging (daughter cysts, water-lily sign) and serology, and treated with albendazole plus PAIR or surgery while scrupulously avoiding spillage.
SURGICAL PRINCIPLES
The surgical principles for hydatid disease centre on removing the cyst without spilling its contents: the field is packed off with swabs soaked in a scolicidal agent (hypertonic saline or cetrimide), the cyst is carefully aspirated and the scolicide instilled to kill the germinal layer before the cyst is opened, and the contents are removed intact where possible. Options range from conservative cystectomy/pericystectomy to, rarely, formal liver resection, always under cover of albendazole to reduce the risk of recurrence from spilled scolices.
🔑KEY POINTS TO REMEMBER- Hydatid cyst = larval Echinococcus granulosus (dog tapeworm; sheep intermediate host; human accidental host); liver (right lobe) commonest site.
- Slow-growing; often asymptomatic → RUQ mass/pain/hepatomegaly; complications: rupture (anaphylaxis + dissemination), infection, biliary rupture.
- Ultrasound/CT (daughter cysts, 'water-lily sign') + serology (ELISA).
- Treat with albendazole + PAIR or surgery (pericystectomy); avoid spillage — instil a scolicidal agent (risk of anaphylaxis/dissemination).
📚SOURCES: Bailey & Love's Short Practice of Surgery; SRB's Manual of Surgery.